The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA69092024 - Pharmaceutical Evaluations Management EOI closed on Friday, 26 April 2024. Appointments were made. Ref: SAHPRA20862023 - The EOI...
Pretoria, 16 September 2024 –The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has received its first clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2023/2024 financial year, following on a record of consistent unqualified audit...
Pretoria, 22 July 2024 –The South African Health Products Regulatory Authority (SAHPRA) is disappointed with the unfounded fallacies and misrepresentation in circulation and churned out by some media organisations without verification, in what presents as a misinformation campaign devoid of any intent to rely on...
The South African Association of Pharmacists in Industry (SAAPI) held its 2024 conference at the Council for Scientific and Industrial Research (CSIR) International Convention Centre on 5-7 June 2024 under the theme “Engage and empower: Pushing the frontiers of the Pharma Industry”. South African Health Products...
Pretoria, 05 June 2024 –On 13 April 2024, the South African Health Products Regulatory Authority (SAHPRA) initiated a precautionary recall of two batches of Benylin Paediatric Syrup (batch numbers 329303 and 329304), in response to reported high levels of diethylene glycol in an alert by...
Pretoria, 29 May 2024 –The South African Health Products Regulatory Authority (SAHPRA) has attained its ISO 9001:2015 certification following a rigorous audit by the South African Bureau of Standards (SABS), a milestone that serves as a testament to the implementation of an effective and robust...
Pretoria, South Africa, 28 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) and the Botswana Medicines Regulatory Authority (BoMRA) have signed a memorandum of understanding (MoU) that will see the two regulators partner on various areas to improve access to new medicines...
Pretoria, 13 April 2024 – On 10 April 2024, the South African Health Products Regulatory Authority (SAHPRA) received a report from the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) regarding the detection of high levels of diethylene glycol in a batch...
Kigali - Rwanda, 12 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Rwanda Food and Drug Authority (Rwanda FDA). The MOU between SAHPRA and Rwanda FDA will allow the regulators to develop a cooperative...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the third cohort of graduates who successfully completed the short course for Clinical Assessors within African...
